Table 3.
Diets | |||
---|---|---|---|
Control | 11% PPC | ||
SFAs | 33.89 ± 0.86 | 29.31 ± 1.77 *** | |
C14:0 | 0.47 ± 0.11 | 0.62 ± 0.10 * | |
C16:0 | 18.42 ± 1.26 | 18.82 ± 0.91 | |
C18:0 | 13.62 ± 1.91 | 8.47 ± 1.23 *** | |
C20:0 | 0.05 ± 0.00 | 0.04 ± 0.00 *** | |
C22:0 | 0.12 ± 0.02 | 0.07 ± 0.01 *** | |
MUFAs | 20.06 ± 3.19 | 20.40 ± 1.71 | |
C16:1n-7 | 2.39 ± 1.02 | 3.13 ± 0.85 | |
C16:1n-9 | 0.25 ± 0.06 | 0.27 ± 0.04 | |
C18:1n-7 | 4.08 ± 1.12 | 3.41 ± 0.69 | |
C18:1n-9 (OA) | 12.52 ± 1.64 | 12.81 ± 0.87 | |
C20:1n-7 | 0.11 ± 0.02 | 0.14 ± 0.01 ** | |
C20:1n-9 | 0.19 ± 0.03 | 0.12 ± 0.01 *** | |
C22:1n-7 | 0.01 ± 0.00 | 0.01 ± 0.00 | |
C22:1n-9 | 0.05 ± 0.03 | 0.02 ± 0.00 | |
C24:1n-9 | 0.17 ± 0.03 | 0.13 ± 0.02 * | |
PUFAs | 45.91 ± 2.74 | 50.20 ± 1.30 * | |
n-9 PUFAs | 0.17 ± 0.02 | 0.08 ± 0.00 *** | |
C20:3n-9 (MA) | 0.17 ± 0.02 | 0.08 ± 0.00 *** | |
n-6 PUFAs | 39.13 ± 2.74 | 22.13 ± 1.36 *** | |
C18:2n-6 (LA) | 14.80 ± 1.87 | 15.72 ± 1.40 | |
C18:3n-6 (GLA) | 0.20 ± 0.03 | 0.09 ± 0.01 *** | |
C20:3n-6 (DGLA) | 1.04 ± 0.38 | 0.71 ± 0.09 | |
C20:4n-6 (AA) | 21.96 ± 2.13 | 5.30 ± 0.91 *** | |
C22:4n-6 | 0.44 ± 0.06 | 0.07 ± 0.01 *** | |
C22:5n-6 (DPA) | 0.29 ± 0.09 | 0.05 ± 0.01 *** | |
n-3 PUFAs | 6.61 ± 0.61 | 27.98 ± 2.16 *** | |
C18:3n-3 (ALA) | 0.42 ± 0.10 | 1.47 ± 0.29 *** | |
C18:4n-3 | 0.02 ± 0.01 | 0.26 ± 0.08 *** | |
C20:4n-3 | 0.09 ± 0.01 | 0.68 ± 0.18 *** | |
C20:5n-3 (EPA) | 0.37 ± 0.05 | 10.82 ± 0.94 *** | |
C21:5n-3 (HPA) | 0.00 ± 0.00 | 0.36 ± 0.07 *** | |
C22:5n-3 (DPA) | 0.73 ± 0.09 | 4.54 ± 0.68 *** | |
C22:6n-3 (DHA) | 4.98 ± 0.67 | 9.85 ± 0.97 *** |
1 Data were analyzed with t-test (n = 6), and are presented as means ± SD of wt % (g fatty acids/100 g of total hepatic fatty acids). Values significantly different from control are indicated (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). Abbreviations: See Table 1.